Biosimilars Market Size to Surpass US$ 66.2 Billion by 2030 Ottawa, Nov. 18, 2021 (GLOBE NEWSWIRE) -- The global biosimilars market size was reached at US$ 13.2 billion in 2020. The rising prevalence of diseases and the effective treatment of these chronic...

Global Biosimilars Market Is Estimated to Grow at a CAGR of +6% by 2025 Top Companies are Pfizer, Sandoz, Teva Pharmaceuticals, Amgen, Biocon, Dr. Reddy’s Laboratories, Celltrion PUNE, India, July 05, 2019 (GLOBE NEWSWIRE) -- Global Biosimilars Industry was valued at USD $7.75 Billion in the year 2019. Global Biosimilars Industry is further estimated to grow at a CAGR of...

The Biosimilars Market will hit $69 billion by 2025: Global Market Insights, Inc. Selbyville, Delaware, May 22, 2019 (GLOBE NEWSWIRE) -- Recombinant glycosylated proteins segment of biosimilars market is estimated to grow at around 28.7% over the estimation period. Increase in...

Biosimilars Market Size to Reach $26.7 Billion by 2024: P&S Intelligence NEW YORK, April 15, 2019 (GLOBE NEWSWIRE) -- According to the market research report published by P&S Intelligence, biosimilars market is expected to generate $26.7 billion revenue by 2024,...

Biosimilars Market Size Is Projected To Reach $41.7 Billion, Demand In Various End-use Industries Till 2024: Grand View Research, Inc. San Francisco, July 19, 2016 (GLOBE NEWSWIRE) -- The biosimilars market is expected to reach USD 41.7 billion by 2024, according to a new report by Grand View Research, Inc. The global...